SCNX ▲ +3.4% - Scienture Holdings, Inc. $SCNX - SCIENTURE Issues Shareholder Letter Highlighting Sequential Revenue Growth, Two FDA-Approved Commercial Products, and Continued Progress Toward Profitability in 2027 22-OCT-2026 08:05 AM ET